Boston University Rheumatology Research Training (BURRT) T32 Program06/01/2022 - 05/31/2027 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases1T32AR080623-01
PRROPS: Pathways of Risk and Resilience for Overlapping Pain and Sensitization07/15/2021 - 04/30/2026 (Multi-PI)
PI:
Tuhina Neogi, MD, PhDNIH/National Institute of Neurological Disorders & Stroke3R01NS121419-02S1
Pain in community-based older African American Adults: The Jackson Heart Study09/30/2020 - 05/31/2025 (Multi-PI)
PI:
Tuhina Neogi, MD, PhDNIH/National Institute on Aging5R01AG066914-03
CAPSITE: Community Assessment of Pain and Sensitization in the Elderly01/01/2020 - 11/30/2024 (Multi-PI)
PI:
Tuhina Neogi, MD, PhDNIH/National Institute on Aging5R01AG066010-03
The impact of axial spondyloarthritis treatment on chronic opioid use07/01/2022 - 10/30/2024 (Key Person / Mentor)
PI:
Jean W. Liew, MD MSRheumatology Research Foundation
Healthy Knee Aging Vs. Osteoarthritis in Three Large Diverse Cohorts: What Is the Clinical Relevance of Structural Changes Seen on Radiographs?09/27/2021 - 08/31/2024 (Subcontract PI)
Arizona Board of Regents, University of Arizona NIH NIAMS1R01AR078187-01
Group-based mindfulness for patients with chronic low back pain in the primary care setting09/01/2020 - 08/31/2024 (Subcontract PI)
Boston Medical Center Corporation NIH NCCIH5UH3AT010621-03
Curriculum to Grow Diversity in the Rheumatology Workforce: Boston University Rheumatology01/02/2023 - 12/31/2023 (Multi-PI)
PI:
Tuhina Neogi, MD, PhDArthritis Foundation
A randomized, two-arm controlled, participant and investigator-blinded study investigating the efficacy, safety and tolerability of DFV890 in patients with symptomatic knee osteoarthritis01/24/2022 - 11/30/2023 (PI)
Novartis Pharmaceuticals Corporation
CARE (Creating and Advancing Research Equity) across BUSM10/15/2021 - 10/14/2023 (Multi-PI)
PI:
Tuhina Neogi, MD, PhDDoris Duke Charitable Foundation John Templeton Fdn
Showing 10 of 35 results.
Show All Results
Risk factors for anterior knee pain and the relation to future patellofemoral osteoarthritis09/01/2021 - 08/31/2023 (Subcontract PI)
Northeastern University NIH NIAMS1R03AR077698-01A1
VOCES: A Peer Advocacy Program for Latinx Patients with Rheumatic Conditions07/01/2021 - 06/30/2023 (Key Person / Mentor)
PI:
Monica Crespo-Bosque, MDRheumatology Research Foundation
Wearable sensor-based Outcomes Following Physical Therapy in Knee Osteoarthritis: A Feasibility Study (WESENS-OA)12/20/2019 - 06/30/2023 (Multi-PI)
PI:
Tuhina Neogi, MD, PhDPfizer, Inc.
Optimizing the value of pain management in knee osteoarthritis patients with comorbidities08/01/2018 - 06/30/2023 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NIAMS5R01AR074290-05
The Role of Urate in Knee Osteoarthritis-Related Inflammation, Pathology and Pain02/01/2017 - 06/30/2023 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases5K24AR070892-05
Evaluation of neuropathic-like symptoms and objective signs of neuropathy post-knee replacement in patient with knee osteoarthritis12/01/2020 - 09/01/2022 (PI)
Rheumatology Research Foundation
Pain sensitization in a trial of physical therapy for OA and meniscal tear09/12/2019 - 08/30/2021 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NIAMS5R21AR076156-02
Rapidly Progressive Osteoarthritis of the Knee – Frequency and Risk Factors: A Collaborative Epidemiology Study of the Pooled Osteoarthritis Initiative (OAI) and Multicenter Osteoarthritis Study (MOST06/01/2020 - 06/01/2021 (PI)
Regeneron Pharmaceuticals, Inc.
Relation of allopurinol to renal function in patients with gout and chronic kidney disease05/15/2020 - 05/01/2021 (PI)
Horizon Pharma USA
Group-based mindfulness for patients with chronic pain in the primary care setting09/28/2019 - 08/31/2020 (Subcontract PI)
Boston Medical Center Corporation NIH NCCIH1UG3AT010621-01
Sprifermin Program06/11/2018 - 12/31/2019 (PI)
EMD Serono Research & Development Institute, Inc.
Central Sensitization in Post-knee replacement pain and relation to OA pathology09/01/2016 - 08/31/2019 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases4R01AR062506-05
Central Pain Mechanisms, Pain Intensity and Drug Response in Rheumatoid Arthritis01/01/2018 - 06/30/2019 (Subcontract PI)
Northwestern University NIH NIAMS7R01AR064850-06
Central Pain Mechanisms, Pain Intensity and Drug Response in Rheumatoid Arthritis07/01/2016 - 12/31/2017 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NIAMS5R01AR064850-05
Central Pain Mechanisms, Pain Intensity and Drug Response in Rheumatoid Arthritis07/01/2013 - 06/30/2017 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NIAMS5R01AR064850-03
Bisphosphate Effects in Knee Osteoarthritis05/01/2014 - 04/30/2017 (PI)
Arthritis Foundation
Aromatase inhibitor-associated arthralgias: Characterization of the effect of estrogen depletion on pain11/01/2015 - 01/31/2017 (PI)
Rheumatology Research Foundation
Central Sensitization in Post-knee replacement pain and relation to OA pathology09/14/2012 - 08/31/2016 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases5R01AR062506-04
NIAMS Multidisciplinary Clinical Research Center08/01/2012 - 07/31/2016 (Co-Investigator of Sub-Project / SP)
PI:
David T. Felson, MD, MPHNIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases5P60AR047785-14
Do Omega-3 Fatty Acids Reduce Risk of Recurrent Gout Attacks?10/01/2014 - 01/31/2016 (PI)
Rheumatology Research Foundation
Understanding Mortality in Knee Osteoarthritis07/01/2012 - 06/30/2014 (Co-Investigator)
PI:
Devyani Misra, MBBSArthritis Foundation
Predictors and Consequences of Subchondral Bone Attrition in Osteoarthritis09/14/2007 - 08/31/2013 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases5K23AR055127-05
Bone Attrition in Osteoarthritis: Interplay of Cartilage Loss, Malalignment, and Bone Density07/01/2007 - 06/30/2010 (PI)
American College of Rheumatology Research and Education Foundation
Vitamin K Deficiency, Chondrocalcinosis, and Osteoarthritis07/01/2004 - 06/30/2007 (PI)
Abbott Laboratories
Vitamin K Deficiency, Chondrocalcinosis, and Osteoarthritis07/01/2003 - 06/30/2006 (PI)
Arthritis Foundation
Phase 3 multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy04/27/2020 - 04/27/2023 (PI)
Novartis Pharma Corp